Your search returned 3 results.

Results
	1.	Basiliximab reduces the incidence of acute cellular rejection in live-related-donor kidney transplantation: a three-year prospective randomized trial. [electronic resource] by Sheashaa, Hussein A Bakr, Mohamed A Ismail, Amany M Sobh, Mohamed A Ghoneim, Mohamed A Producer: 20030725 In: Journal of nephrology vol. 16 Availability: No items available. Save to lists Add to cart (remove)
	2.	Long-term evaluation of basiliximab induction therapy in live donor kidney transplantation: a five-year prospective randomized study. [electronic resource] by Sheashaa, Hussein A Bakr, Mohamed A Ismail, Amany M Gheith, Osama E El-dahshan, Khalid F Sobh, Mohamed A Ghoneim, Mohamed A Producer: 20051027 In: American journal of nephrology vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Is it worth using daclizumab induction therapy with mycophenolate mofetil-based immunosuppressive regimens in live related donor kidney transplantation? A long-term follow up. [electronic resource] by Sheashaa, Hussein A Bakr, Mohamed A Fouda, Mohamed Ashraf El-Dahshan, Khalid F Ismail, Amany M Sobh, Mohamed A Ghoneim, Mohamed A Producer: 20071128 In: International urology and nephrology vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search